Pulse Biosciences
PLSE
42 hedge funds and large institutions have $20.4M invested in Pulse Biosciences in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 9 closing their positions.
9% more capital inflows, than outflows
Capital inflows: $1.76M | Capital outflows: $1.62M
1.74% less ownership
Funds ownership: 10.39% → 8.65% (-1.7%)
9% less funds holding
Funds holding: 46 → 42 (-4)
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$469K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$439K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$243K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$168K |
| 5 |
FC
Fore Capital
New York
|
+$155K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Harvest Capital Strategies
San Francisco,
California
|
-$497K |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$246K |
| 3 |
GSA Capital Partners
London,
United Kingdom
|
-$170K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$123K |
| 5 |
Bank of New York Mellon
New York
|
-$108K |
PLSE Hedge Fund Activity: Q4 2018 in Review
42 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2018, worth a combined $20.4M — down 18% from $24.9M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PLSE and 5 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 10 added.
The largest buyer was Geode Capital Management, adding an estimated $469K. The largest seller was Harvest Capital Strategies, exiting entirely with an estimated $497K sold.
- 42 institutional investors held Pulse Biosciences (PLSE) as of Q4 2018, down from 46 in Q3 2018.
- Funds reported $20.4M of Pulse Biosciences stock for Q4 2018, down 18% quarter-over-quarter.
- 5 funds opened new Pulse Biosciences positions in Q4 2018 and 9 closed out, a net change of -4 holders.
- The largest Pulse Biosciences buyer in Q4 2018 was Geode Capital Management, an estimated $469K added.
- The largest Pulse Biosciences seller in Q4 2018 was Harvest Capital Strategies, an estimated $497K sold.
Based on aggregated 13F filings for Q4 2018.